W
WAVEMAN · COMPANY
TEVA · Teva Pharmaceutical Industries Ltd
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD
PHARMA & BIOTECH · PHARMACEUTICAL PREPARATIONS · CIK 0000818686
FORM 144 · 4☆ WATCH
INSIDER NET · 180D
-$23.1M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
365
13F, latest reported quarter
REVENUE GROWTH
+4.3%
XBRL, annual
NET MARGIN
8.2%
CONVERSIONS · 180D
16
codes C/M, not in net · $49.0K priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$23.1M over 180 days
-$6.3M over 90 days
below 89% of Pharma & Biotech
CONGRESS
no member of Congress has reported trading it
FUNDS
365 funds added or opened last quarter
more than 94% of Pharma & Biotech
REVENUE
+4.3% year over year
more than 53% of Pharma & Biotech
MARGIN
8.2% net margin
more than 78% of Pharma & Biotech
BUYBACKS
no share repurchases reported
SHORT
no short interest reported
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$23.1M across 12 people in 180 days.
365 funds added or opened positions in the latest 13F quarter, of 676 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +93.9%
+93.9%12M
-2%+33%+68%+103%2025-092025-102025-122026-032026-052026-072026-09 2026-03-03 · Francis Richard D sold $13.3M2026-02-26 · Kalif Eliyahu Sharon sold $11.6M2026-02-15 · Francis Richard D sold $9.8M2026-02-15 · Francis Richard D sold $5.5M2026-05-14 · Kalif Eliyahu Sharon sold $5.5M2026-05-01 · Sabag Mark sold $5.0M2025-11-06 · MIGNONE ROBERTO sold $4.8M2026-06-11 · Kalif Eliyahu Sharon sold $3.6M2025-12-09 · Sabag Mark sold $3.4M2025-12-09 · Daniell Richard sold $3.3M2025-12-09 · Sabag Mark sold $2.8M2025-12-16 · MIGNONE ROBERTO sold $2.3M2026-03-03 · Hughes Eric A sold $2.2M2026-03-03 · Daniell Richard sold $2.2M2026-03-03 · Daniell Richard sold $2.0M2026-03-17 · Sabag Mark sold $1.9M2025-11-26 · MIGNONE ROBERTO sold $1.3M2026-05-14 · Lippman Evan sold $1.3M2026-03-04 · Daniell Richard sold $1.2M2026-03-04 · Daniell Richard sold $1.1M2026-05-05 · Daniell Richard sold $1.1M2026-03-03 · Francis Richard D sold $1.0M2026-08-03 · Hughes Eric A sold $892.1K2026-03-04 · Francis Richard D sold $759.3K2025-11-14 · Fox Christine sold $753.3K2026-04-30 · Fox Christine sold $750.6K2025-11-20 · Fox Christine sold $699.5K2026-08-17 · Lippman Evan sold $680.3K2026-03-04 · Daniell Richard sold $664.2K2026-03-05 · Francis Richard D sold $634.2K2026-03-05 · Daniell Richard sold $547.7K2026-03-05 · Shields Matthew sold $547.7K2026-06-03 · Shields Matthew sold $532.3K2026-03-05 · Jover Placid sold $448.1K2026-08-03 · Jover Placid sold $447.4K2026-03-03 · Hughes Eric A sold $390.8K2026-05-06 · Weiss Amir sold $384.4K2025-12-16 · Weiss Amir sold $371.5K2026-03-04 · Hughes Eric A sold $366.1K2026-06-18 · Shields Matthew sold $321.5K2026-03-05 · Hughes Eric A sold $301.9K2025-11-06 · Weiss Amir sold $300.6K2026-08-17 · Lippman Evan filed to sell $680.3K2026-08-03 · Hughes Eric A filed to sell $892.1K2026-08-03 · Jover Placid filed to sell $447.4K2026-06-18 · Shields Matthew filed to sell $321.5K
INSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $23.1M sold by insiders over 180 days, 365 funds added last quarter, $2.3M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
UTHRCPIXMRNAREGNLLYALNYELFCITRMDGLDNAVRTXNUVL
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, TEVA PHARMACEUTICAL INDUSTRIES LTD insiders sold a net $23.1M of stock across 160 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
Satchi-Fainaro Ronit
Director
SELL
2026-08-21
415.0
$15.5K
Weiss Amir
Chief Accounting Officer
SELL
2026-08-21
6,945.0
$261.2K
Weiss Amir
Chief Accounting Officer
SELL
2026-08-21
2,500.0
$94.1K
Lippman Evan
EVP, Business Development
SELL
2026-08-17
18,600.0
$680.3K
Zaks Tal Zvi
Director
SELL
2026-08-05
17.0
$593
160 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 155 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BlackRock, Inc.
63,894,301.0 sh
$2.2B
Phoenix Financial Ltd.
42,933,367.0 sh
$1.5B
WCM INVESTMENT MANAGEMENT, LLC
41,315,232.0 sh
$1.4B
MENORA MIVTACHIM HOLDINGS LTD.
39,854,383.0 sh
$1.4B
Migdal Insurance & Financial Holdings Ltd.
38,922,212.0 sh
$1.3B
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
Lippman Evan
FILED 2026-08-17
$680.3K
Hughes Eric A
FILED 2026-08-03
$892.1K
Jover Placid
FILED 2026-08-03
$447.4K
Shields Matthew
FILED 2026-06-18
$321.5K
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
VanEck Israel ETF
$14.2M POSITION · AS OF 2026-03-31
10.4%
iShares MSCI Israel ETF
$83.9M POSITION · AS OF 2026-02-28
9.9%
Upright Growth Fund
$2.0M POSITION · AS OF 2026-03-31
8.2%
Catalyst Insider Buying Fund
$1.2M POSITION · AS OF 2026-03-31
7.9%
Vistashares Target 15 Drukmacro Distribution ETF
$1.3M POSITION · AS OF 2026-04-30
6.6%
ALGER HEALTH SCIENCES FUND
$2.8M POSITION · AS OF 2026-04-30
4.6%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$17.3B$16.5B$15.8B$14.9B
GROSS PROFIT$8.9B$8.1B$7.6B$7.0B
OPERATING INCOME$2.2B$-303.0M$433.0M$-2.2B
NET INCOME$1.4B$-1.6B$-559.0M$-2.4B
EPS (DILUTED)1.21-1.45-0.50-2.20
OPERATING CASH FLOW$1.6B$1.2B$1.4B$1.6B
CASH$3.6B$3.3B$3.2B$2.8B
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →